跳至主要内容
临床试验/EUCTR2013-004979-13-DK
EUCTR2013-004979-13-DK进行中(未招募)1 期

Treatment of Preoperative Anaemia in Patients with Urogenital Cancer: A Randomised Double-Blind Placebo-Controlled Study of Intravenous Iron Isomaltide 1000 Monofer© versus Saline

Rigshospitalet, 20320 个研究点开始时间: 2014年1月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Anaemia: males Hb< 13g/dL (8.0 mmol/L), females Hb< 11.3 g/dL (7.0 mmol/L)
  • Age > 18 years
  • Iron deficiency anaemia and anaemia of chronic disease: P-Ferritin<100ug/L eller P-Ferritin 100-800ug/L og TSAT<20 %
  • Able to give informed consent vulantary
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 24

排除标准

  • Anaemia< Hb= 8 g/dL (5.0mmol/L) or anaemia related to other causes than iron deficiency anaemia and anaemia of chronic disease
  • Known hypersensibility to intravenous iron
  • Acute or chronic infection (assessed by clinical judgement supplied with WBC and CRP)
  • Decompensated liver cirrhosis or hepatitis (ALAT>3x normal)
  • Rheumatoid arthritis with symptoms or signs of acute inflammation (assessed by clinical judgement and CRP)
  • Haemosiderosis or haemochromatosis
  • RBC transfusion two weeks prior inclusion
  • Intravenous iron or ESA four weeks prior inclusion
  • Uraemia with creatinine>250 umol/L or haemodialysis
  • Participating in another clinical study

研究者

发起方
Rigshospitalet, 2032

相似试验